Malaria project in funding crisisApril 25, 2003Study says WHO initiative "will fail" without increase in aid The World Health Organisation's (WHO) goal to reduce malaria deaths by 75% by 2015 looks set to fail due to lack of international aid, according to Harvard researchers. An article published this month in the online open access Malaria Journal, states that current funding to fight this killer disease is less than 7% of what is needed. WHO launched the Roll Back Malaria movement (RBM) in 1998 with the World Bank, UNDP and UNICEF. Its goal was to halve malaria deaths by 2010, and again by 2015. RBM set out to do this through detection and treatment of malaria cases, and preventative measures such as bednets treated with insecticide. Experts agree that a budget of US $1.5 to US $2 billion dollars is needed each year to ensure the project's success. The Malaria Journal study's authors, Vasant Narasimhan and Amir Attaran, found that current funding from international aid and loans stands at just US $98.9 million annually. This figure has not increased substantially from the year when RBM was launched. The Malaria Journal study examines the official database of the 23 aid agencies of the world's richest nations, which compiles all funding commitments. To check the accuracy of these findings, the authors also surveyed all of the donors. The authors not only conclude that aid and World Bank loans are drastically under what is required, they criticise the bookkeeping of the RBM. Narasimhan and Attaran call for more transparent reporting by donors, and audits by the RBM. The authors also express concerns that what little money is being donated is not being spent in the countries that need it most. Malaria is second only to HIV/AIDS of the infectious diseases claiming lives globally. 90% of cases occur in Africa where one million people die from malaria each year, of which 70% are women and children. BioMed Central Limited |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles Measuring and modeling blood flow in malaria When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||